Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
HHCA Healthcare Inc. logo
HCANYSE

HCA Healthcare Inc.

HCA Healthcare Inc.
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Sep 16
Ex-dividend Time TBD
Ex-dividend (predicted) $0.78
Add to Google Calendar
Jul 30
Filing Time TBD
Quarterly report (10-Q) filing due (est.)
Add to Google Calendar
Jul 24
Earnings 10:00
Earnings call (第2四半期)
Add to Google Calendar
Earnings 7:00
Q2 earnings
Add to Google Calendar
Apr 24
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Jan 27
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2025
Oct 24
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Jul 25
Earnings Time TBD
Q2 earnings
Add to Google Calendar
Apr 25
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Oct 23
Est.
Earnings 7:10 approx.
Q3 earnings (predicted)
Add to Google Calendar
Dec 17
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $0.78
Add to Google Calendar
2027
Jan 22
Est.
Earnings 7:10 approx.
FY earnings (predicted)
Add to Google Calendar
Feb 15
Est.
Filing Time TBD
Annual report (10-K) filing due (est.)
Add to Google Calendar
Apr 28
Est.
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar
Past events
2026
Sep 16
Ex-dividend Time TBD
Ex-dividend (predicted) $0.78
Add to Google Calendar

KPI highlights

FY25
Revenue $75.60B YoY +7.1%
Operating income $11.96B margin 15.8%
Net income $6.78B YoY +17.8%
EPS $28.70 YoY +28.9%
P/E 12.9× Slightly cheap Rough PER guide (a simplified band — fair value varies by industry and growth stage): <10 Cheap / 10–15 Slightly cheap / 15–22 Fair / 22–35 Slightly rich / ≥35 Rich
ROE -112.6% Sign disagrees with net income (may reflect a one-time accounting item)

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 18,28518,32118,60519,16119,51319,109
Operating income 2,8462,8552,9672,9653,1782,863
Net income 1,6861,8251,8911,9032,1631,857
Operating CF 2,0822,6523,8833,7091,7633,003

Company news

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2013–2026）

機関投資家 28.6%未開示 71.4%20132015201720192021202320252026
機関投資家 28.6%未開示 71.4%13Q214Q315Q417Q118Q219Q320Q422Q123Q224Q326Q1
機関投資家未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

BlackRock, Inc. 3%BlackRock, Inc.VANGUARD CAPITAL M 2.3%VANGUARD CAPITAL MANAGEMENT LLCSanders Capital, L 2%Sanders Capital, LLCSTATE STREET CORP 1.7%STATE STREET CORPFMR LLC 1%FMR LLCWELLINGTON MANAGEM 0.9%WELLINGTON MANAGEMENT GROUP LLPGEODE CAPITAL MANA 0.8%GEODE CAPITAL MANAGEMENT, LLCFirst Eagle Invest 0.7%First Eagle Investment Management, LLCCapital Internatio 0.7%Capital International InvestorsVANGUARD PORTFOLIO 0.6%VANGUARD PORTFOLIO MANAGEMENT LLC20132015201720192021202320252026
BlackRock, Inc. 3%BlackRock, Inc.VANGUARD CAPITAL M 2.3%VANGUARD CAPITAL MANAGEMENT LLCSanders Capital, L 2%Sanders Capital, LLCSTATE STREET CORP 1.7%STATE STREET CORPFMR LLC 1%FMR LLCWELLINGTON MANAGEM 0.9%WELLINGTON MANAGEMENT GROUP LLPGEODE CAPITAL MANA 0.8%GEODE CAPITAL MANAGEMENT, LLCFirst Eagle Invest 0.7%First Eagle Investment Management, LLCCapital Internatio 0.7%Capital International InvestorsVANGUARD PORTFOLIO 0.6%VANGUARD PORTFOLIO MANAGEMENT LLC13Q214Q315Q417Q118Q219Q320Q422Q123Q224Q326Q1

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
その他機関投資家（13F 1313社） 43,334,639 9.8% 13F
BlackRock, Inc. 13,363,266 3.0% 13F
VANGUARD CAPITAL MANAGEMENT LLC 10,178,362 2.3% 13F
Sanders Capital, LLC 8,957,145 2.0% 13F
STATE STREET CORP 7,539,550 1.7% 13F
FMR LLC 4,401,023 1.0% 13F
WELLINGTON MANAGEMENT GROUP LLP 3,907,712 0.9% 13F
GEODE CAPITAL MANAGEMENT, LLC 3,692,513 0.8% 13F
First Eagle Investment Management, LLC 3,194,079 0.7% 13F
Capital International Investors 3,033,612 0.7% 13F
VANGUARD PORTFOLIO MANAGEMENT LLC 2,757,779 0.6% 13F
MORGAN STANLEY 2,294,880 0.5% 13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2,165,258 0.5% 13F
GOLDMAN SACHS GROUP INC 2,136,072 0.5% 13F
Capital World Investors 1,972,429 0.4% 13F
NORTHERN TRUST CORP 1,752,127 0.4% 13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1,500,000 0.3% 13F
NORDEA INVESTMENT MANAGEMENT AB 1,447,549 0.3% 13F
Invesco Ltd. 1,438,525 0.3% 13F
BARCLAYS PLC 1,248,315 0.3% 13F
FRANKLIN RESOURCES INC 1,216,596 0.3% 13F
Legal & General Group Plc 1,094,799 0.2% 13F
VIKING GLOBAL INVESTORS LP 1,075,133 0.2% 13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,071,563 0.2% 13F
Bank of New York Mellon Corp 944,231 0.2% 13F
VANGUARD FIDUCIARY TRUST CO 886,570 0.2% 13F

Source：SEC EDGAR（DEF 14A・13D/G・13F）　Classification inferred from disclosed names

F-Score (Piotroski)

4/7 1 of 7 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

ROE and related signals above include a period where the sign disagrees with net income due to a one-time accounting item (see the ROE note in the KPI highlights above).

— Positive ROAExcluded from this period due to the net income/ROE sign mismatch N/A
✓ Positive operating cash flow $12.64B
— ROA improved YoYExcluded from this period due to the net income/ROE sign mismatch N/A
✓ Operating CF exceeds net income (accrual quality) OCF $12.64B / net income $6.78B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” -4.2% → -9.9%
✗ Current ratio improved 1.08× → 0.97×
✓ No dilution (shares outstanding did not increase) 249,981,400 → 224,605,100
— Gross margin improved No data
✓ Asset turnover improved 1.19× → 1.25×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio -9.9%
Current ratio 1.0×
Years of positive operating CF 12 of last 12 yrs
Payout ratio 10%
Latest fiscal year result Profit (net income $6.78B)

Performance history

Last 10 years
$0.0B$18.9B$37.8B$56.7B$75.6B FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue ———51,33651,53358,75260,23364,96870,60375,600
Operating income ————7,2629,6789,0539,62710,54711,965
Ordinary income ——————————
Net income 2,8902,2163,7873,5053,7546,9565,6435,2425,7606,784
Total assets 33,75836,59339,20745,05847,49050,74252,43856,21159,51360,720
Equity -7,302-6,806-4,950-2,808572-933-2,767-1,774-2,499-6,027

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS $7.53$6.12$10.90$10.27$11.10$21.52$19.43$19.25$22.27$28.70
ROE -39.6%-32.6%-76.5%-124.8%656.3%-745.6%-203.9%-295.5%-230.5%-112.6%
Operating CF 5,6535,4266,7617,6029,2328,9598,5229,43110,51412,636
Investing CF -3,240-4,279-3,901-5,720-3,393-2,643-3,389-5,317-4,933-4,988
Financing CF -2,508-1,061-3,075-1,771-4,677-6,655-5,656-4,094-4,582-8,550
FCF ————6,3975,3824,1274,6875,6397,692

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-03) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data